STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31
STERIS plc
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$221.97−0.69 (-0.31%)
Close on Oct 19, 2026
- Market cap
- $21.73B
- P/E (TTM)
- 27.1
- Dividend yield
- 1.11%
Share price
−$18.24 (−7.59%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
STERIS plc grew revenue 8.4% to $6.04B over the twelve months to Jun 30, 2026. Operating income rose 23.1% to $1.14B, moving the operating margin from 16.6% to 18.9%. Free cash flow was $925.60M, up 1.8% from a year earlier.
Revenue
$6.04B
+8.4% vs. a year earlier
Operating income
$1.14B
+23.1% vs. a year earlier
Free cash flow
$925.60M
+1.8% vs. a year earlier
EPS, diluted
$8.18
+25.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $21.73B
- P/E ratio
- 27.1
- Price to sales
- 3.60
- Price to book
- 3.02
- Dividend yield
- 1.11%
- Free cash flow yield
- 4.26%
Fundamentals
- Revenue
- $6.04B
- Net income
- $805.10M
- EPS, diluted
- $8.18
- Free cash flow
- $925.60M
- Book value per share
- $73.61
- Diluted shares
- 98M
Eleven years at a glance
Fiscal years 2016 to 2026 and trailing twelve months, USD
Revenue
$6.04B+8.4% YoY
Gross profit
$2.68B+9.1% YoY
Operating income
$1.14B+23.1% YoY
Net income
$805.10M+24.5% YoY
EPS, diluted
$8.18+25.5% YoY
Free cash flow
$925.60M+1.8% YoY
Reported periodTrailing twelve months